RELB and melanoma: Consistent with these results, pharmacological inhibition of DDR using imatinib that impaired melanoma MMDR by triggering cell cycle arrest and apoptosis decreased in a time‐dependent manner the expression of RelB in 1205Lu cells cultured in MMDR conditions (Fig EV5B).